3 recalls found for LEVOTHYROXINE SODIUM. Check if any of your products are affected.
Macleods Pharma USA, Inc. recalls 1,315 bottles of Levothyroxine Sodium Tablets USP 150 mcg distributed nationwide. The drug is subpotent, which may not provide the full therapeutic dose. Stop using and contact your healthcare provider or Macleods Pharma USA, Inc. for guidance.
Alvogen, Inc. recalled Levothyroxine Sodium Tablets on January 21, 2026, after a pharmacy reported a mix-up with dosages. Some bottles contained 88 mcg tablets instead of the prescribed 150 mcg. The recall affects 1,000 tablets from lot # MHA21825, with an expiration date of December 31, 2027.
Accord Healthcare recalled 54,432 bottles of Levothyroxine Sodium Tablets on September 16, 2025. The tablets were found to be subpotent during stability testing. Consumers should stop using the product immediately and seek guidance from healthcare providers.